Select Medical (NYSE:SEM) Lowered to Hold Rating by StockNews.com

StockNews.com downgraded shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a research report report published on Thursday morning.

Several other research firms have also issued reports on SEM. UBS Group lowered their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Royal Bank of Canada lifted their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $39.50.

Select Medical Stock Up 2.7 %

SEM stock opened at $18.74 on Thursday. The business has a 50 day moving average of $19.25 and a 200 day moving average of $28.82. The firm has a market cap of $2.43 billion, a PE ratio of 8.75, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45. Select Medical has a twelve month low of $18.02 and a twelve month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 19.14% of the company’s stock.

Institutional Trading of Select Medical

A number of hedge funds have recently bought and sold shares of the company. Ceredex Value Advisors LLC grew its position in Select Medical by 6.7% during the fourth quarter. Ceredex Value Advisors LLC now owns 267,150 shares of the health services provider’s stock valued at $5,036,000 after buying an additional 16,800 shares during the period. Barclays PLC increased its stake in shares of Select Medical by 29.6% in the 4th quarter. Barclays PLC now owns 249,209 shares of the health services provider’s stock worth $4,698,000 after purchasing an additional 56,852 shares in the last quarter. Sterling Capital Management LLC raised its holdings in Select Medical by 9.5% in the 4th quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider’s stock worth $213,000 after purchasing an additional 978 shares during the period. Covestor Ltd lifted its position in Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider’s stock valued at $93,000 after purchasing an additional 1,244 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in Select Medical during the fourth quarter valued at about $5,858,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.